<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Posttransplantation <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) is one of the well-recognized complications after allogeneic stem cell transplantation (SCT) </plain></SENT>
<SENT sid="1" pm="."><plain>It generally occurs early after SCT, and only a few reports of <z:hpo ids='HP_0003584'>late-onset</z:hpo> cases are available </plain></SENT>
<SENT sid="2" pm="."><plain>We report a 58-year-old male patient who developed <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 4 years after allogeneic SCT for <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of c-myc translocation and Epstein-Barr virus-encoded <z:chebi fb="40" ids="33697">RNA</z:chebi> in the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, without rearrangement of the 3'-bcr region, confirmed the histopathologic diagnosis of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>DNA chimerism analysis revealed that the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells were of donor origin </plain></SENT>
<SENT sid="5" pm="."><plain>The patient achieved complete response with intensive chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>To our knowledge, this is the first report of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> as a PTLD occurring after allogeneic SCT </plain></SENT>
</text></document>